CYP2J2 and central nervous system cancer: These lines of evidence showed the involvement of the ERK/CYP2J2/11,12-EET singling pathway in the pro-glioma effect of M2 microglia/TAMs after JWH133 treatment, thus presenting a promising therapeutic target.